Evaluation of salusin-β in paediatric patients with chronic kidney disease or hypertension
Advances in Medical Sciences · 2025
DOI: 10.1016/j.advms.2025.02.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Medical Sciences, 2025. Verfasst von Mirjam Močnik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University Medical Centre Maribor, Maribor, Slovenia. Electronic address: mirjammocnik91@gmail.com. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Hypertension, Intercellular Signaling Peptides and Proteins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PURPOSE: Salusins are newly identified endogenous peptides implicated in the atherosclerotic process. Salusin-β, in particular, is recognized for its proatherogenic role. Given that atherosclerosis can commence in childhood, salusin-β holds promise as a potential biomarker for cardiovascular risk assessment. The objective of our study was to investigate salusin-β levels in children with early stages of chronic kidney disease (CKD) or hypertension (HTN), and compare them to healthy controls. Furthermore, we aimed to evaluate its association with obesity and pulse wave velocity (PWV), the latter being a well-established marker for determining arterial elasticity. MATERIALS AND METHODS: This cross-sectional study involved 96 paediatric patients, including 46 with CKD and 50 with HTN, as well as 33 healthy controls. Anthropometric measurements, PWV assessments, serum salusin-β values, and basic laboratory investigations were conducted for all participants. RESULTS: Salusin-β levels were found to be elevated in patients with CKD (p = 0.014), but not in patients with HTN when compared to healthy controls. When correlating salusin-β levels with PWV, a significant but weak correlation was observed (r = 0.211, p = 0.020). CONCLUSIONS: Salusin-β levels were elevated in paediatric patients with CKD. Additionally, salusin-β levels correlated significantly with PWV. Obesity played a smaller role in these correlations, with significant correlations observed only after combining cardiovascular risk factors revealing certain associations between salusin-β levels and some cardiovascular variables, but with inconclusive findings and, in some instances, even contrary to anticipated outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, University Medical Centre Maribor, Maribor, Slovenia. Electronic address: mirjammocnik91@gmail.com.
- Department of Paediatrics, University Medical Centre Maribor, Maribor, Slovenia.
- Department of Laboratory Diagnostics, University Medical Centre Maribor, Maribor, Slovenia; Faculty of Medicine, University of Maribor, Maribor, Slovenia.
- Department of Laboratory Diagnostics, University Medical Centre Maribor, Maribor, Slovenia.
- Department of Paediatrics, University Medical Centre Maribor, Maribor, Slovenia; Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Zitieren
APA
Močnik, M., Golob Jančič, S., Filipič, M., Homšak, E., Svetej, M., & Marčun Varda, N. (2025). Evaluation of salusin-β in paediatric patients with chronic kidney disease or hypertension. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2025.02.006
Vancouver
Močnik M, Golob Jančič S, Filipič M, Homšak E, Svetej M, Marčun Varda N. Evaluation of salusin-β in paediatric patients with chronic kidney disease or hypertension. Advances in Medical Sciences. 2025. doi:10.1016/j.advms.2025.02.006
BibTeX
@article{Monik2025,
author = {Močnik, Mirjam and Golob Jančič, Sonja and Filipič, Martina and Homšak, Evgenija and Svetej, Mateja and Marčun Varda, Nataša},
title = {Evaluation of salusin-β in paediatric patients with chronic kidney disease or hypertension},
journal = {Advances in Medical Sciences},
year = {2025},
doi = {10.1016/j.advms.2025.02.006}
}
EUVIMED